About this trial
The investigators are doing this study to find out if a new kind of breast imaging (called upright dedicated breast CT or UBCT) can help doctors to see the small structures in breast tissue more clearly in 3-D and without overlap.
The breast imaging device that will be used in this study (UBCT) is not FDA-approved, so this is a research study. The machine has been designed to remove mammography-like breast compression and use radiation dose comparable to mammography. The breast CT device will take multiple x-ray pictures of the subjects breast in approximately 20 seconds and create a 3-D image of the breast. It does not compress or squish the breast like a mammogram.
Eligibility criteria
Qualifiers
(1) who were 40 years of age or older (typical screening age range), and,
(2) who were asymptomatic, and,
(3) who underwent or scheduled to undergo a standard-of-care 2-view bilateral digital breast tomosynthesis screening exam.
(1) who were 40 years of age or older, and,
Disqualifiers
Males
Women less than 40 years old
pregnant or lactating women
women with physical limitations (e.g., kyphosis) that may prohibit UBCT exam
Trial design
Treatments tested in this trial
- Low dose, upright, dedicated breast CT
Treatment groups
Locations
Sponsors and collaborators
University of Arizona
Lead sponsor
National Cancer Institute (NCI)
Collaborator